Ceva Santé Animale and IDT Biologika GmbH

Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portfolio and boosting swine innovation Libourne & Dessau 17th. May 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and R&D activities, allowing IDT to focus on the manufacture of human biotechnology vaccines and pharmaceuticals for national and international markets. The deal is subject to approval by the Federal Cartel Office (Bundeskartellamt) and is expected to be concluded by July 1 2019.